Literature DB >> 15790860

Early lung cancer detection using spiral computed tomography and positron emission tomography.

Gorka Bastarrika1, María José García-Velloso, Maria Dolores Lozano, Usua Montes, Wenceslao Torre, Natalia Spiteri, Arantza Campo, Luis Seijo, Ana Belén Alcaide, Jesús Pueyo, David Cano, Isabel Vivas, Octavio Cosín, Pablo Domínguez, Patricia Serra, José A Richter, Luis Montuenga, Javier J Zulueta.   

Abstract

RATIONALE: Lung cancer screening using computed tomography (CT) is effective in detecting lung cancer in early stages. Concerns regarding false-positive rates and unnecessary invasive procedures have been raised.
OBJECTIVE: To study the efficiency of a lung cancer protocol using spiral CT and F-18-fluorodeoxyglucose positron emission tomography (FDG-PET).
METHODS: High-risk individuals underwent screening with annual spiral CTs. Follow-up CTs were done for noncalcified nodules of 5 mm or greater, and FDG-PET was done for nodules 10 mm or larger or smaller (> 7 mm), growing nodules.
RESULTS: A total of 911 individuals completed a baseline CT study and 424 had at least one annual follow-up study. Of the former, 14% had noncalcified nodules of 5 mm or larger, and 3.6% had nodules of 10 mm or larger. Eleven non-small cell lung cancers (NSCLC) and one small cell lung cancer (SCLC) were diagnosed in the baseline study (prevalence rate, 1.32%), and two NSCLCs in the annual study (incidence rate, 0.47%). All NSCLCs (92% of prevalence cancers) were diagnosed in stage I (12 stage IA, 1 stage IB). FDG-PET was helpful for the correct diagnosis in 19 of 25 indeterminate nodules. The sensitivity, specificity, positive predictive value, and negative predictive value of FDG-PET for the diagnosis of malignancy were 69, 91, 90, and 71%, respectively. However, the sensitivity and negative predictive value of the screening algorithm, which included a 3-month follow-up CT for nodules with a negative FDG-PET, was 100%.
CONCLUSION: A protocol for early lung cancer detection using spiral CT and FDG-PET is useful and may minimize unnecessary invasive procedures for benign lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790860     DOI: 10.1164/rccm.200411-1479OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  36 in total

Review 1.  Lung cancer screening: an update, discussion, and look ahead.

Authors:  Peter J Mazzone
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

2.  Improving selection criteria for lung cancer screening. The potential role of emphysema.

Authors:  Pablo Sanchez-Salcedo; David O Wilson; Juan P de-Torres; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Jesús Pueyo; Gorka Bastarrika; Luis M Seijo; Maria J Pajares; Ruben Pio; Luis M Montuenga; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

Review 3.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

4.  Emphysema scores predict death from COPD and lung cancer.

Authors:  Javier J Zulueta; Juan P Wisnivesky; Claudia I Henschke; Rowena Yip; Ali O Farooqi; Dorothy I McCauley; Mildred Chen; Daniel M Libby; James P Smith; Mark W Pasmantier; David F Yankelevitz
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

Review 5.  Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Authors:  Jiu-Wei Cui; Wei Li; Fu-Jun Han; Yu-Di Liu
Journal:  Transl Lung Cancer Res       Date:  2015-06

Review 6.  Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules.

Authors:  Farise Yilmaz; Gungor Tastekin
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose.

Authors:  Qing Ye; Jing Wu; Yihuan Lu; Mika Naganawa; Jean-Dominique Gallezot; Tianyu Ma; Yaqiang Liu; Lynn Tanoue; Frank Detterbeck; Justin Blasberg; Ming-Kai Chen; Michael Casey; Richard E Carson; Chi Liu
Journal:  Phys Med Biol       Date:  2018-09-06       Impact factor: 3.609

8.  Computed tomography-guided lung biopsy: Association between biopsy needle angle and pneumothorax development.

Authors:  Takumi Kuriyama; Katsuhiro Masago; Yuki Okada; Nobuyuki Katakami
Journal:  Mol Clin Oncol       Date:  2017-11-27

Review 9.  Lung cancer screening.

Authors:  U Pastorino
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

10.  Positron emission tomography in the management of lung cancer.

Authors:  Vahid Reza Dabbagh Kakhki
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.